Led by $17.33bn acquisition of Swedish Match, Europe’s consumer industry saw a drop of 0.39% in cross border deal activity during Q2 2022, when compared to the last four-quarter average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 128 cross border deals worth $22.7bn were announced for the region during Q2 2022, against the last four-quarter average of 128.50 deals.

Of all the deal types, M&A saw most activity in Q2 2022 with 69 deals, representing a 53.9% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

In second place was private equity with 32 deals, followed by venture financing deals with 27 transactions, respectively capturing a 25% and 21.1% share of the overall cross border deal activity for the quarter.

In terms of value of cross border deals, M&A was the leading category in Europe’s consumer industry with $19.62bn, while private equity and venture financing deals totalled $2.79bn and $307m, respectively.

Europe consumer industry cross border deals in Q2 2022: Top deals

The top five consumer cross border deals accounted for a 92.6% share of the overall value during Q2 2022.

The combined value of the top five cross border deals stood at $21.04bn, against the overall value of $22.7bn recorded for the quarter.

1) Philip Morris International $17.33bn acquisition deal with Swedish Match

2) The $1.29bn private equity of Associazione Calcio Milan by RedBird Capital Partners

3) Advent International $1.1bn private equity deal with Irca

4) The $1bn acquisition of Byredo by L’Oreal and Puig

5) Balchem $322.39m acquisition deal with Kappa Bioscience